(La Quinta, CA) Aesthetic Medical Institute (AMI), the leader in advanced medical education, introduces Total Care™, progressive professional skin care formulated to maximize clinical procedure outcomes.

The ingredient profiles found in Total Care™ improve specific skin conditions pre-treatment and enhance post-treatment healing using protocols compatible with oral or topical medications. Total Care™ may be prescribed independently as intensive aesthetic treatments or integrated into medical procedures such as laser resurfacing or plastic surgery. This integrative approach elevates skin care to a higher level by providing the practitioner an opportunity to safely and effectively alter the health of the skin rather than just superficially enhance it. [more]

STUDY SHOWS NEW CANDELA VBEAM PERFECTA LASER
SAFELY TREATS PIGMENTED AND VASCULAR LESIONS
ASSOCIATED WITH PHOTOAGING

- New Technology Proves Improved Efficacy, Higher Purpura Threshold, Fewer Side Effects -

Wayland, MA – November 6, 2006 – A recent study published in The Journal of Lasers in Surgery and Medicine shows that the new micropulse technology of Candela Corporation’s (NASDAQ: CLZR) flagship Vbeam® Pulsed Dye Laser – the Perfecta™, improves efficacy to safely treat vascular and epidermal pigmented lesions while reducing or eliminating undesired side effects such as purpura. The Vbeam Perfecta technology provides patients options when considering skin rejuvenation, fading of sun and age spots, removal of leg and facial veins, treatment of rosacea, dyschromia and more. [more]

ARTEFILL First Product In New Dermal Filler Category

SAN DIEGO–(BUSINESS WIRE)–Artes Medical, Inc., a medical technology company focused on developing, manufacturing and commercializing a new category of aesthetic injectable products for men and women, today announced the United States Food and Drug Administration’s approval of ArteFill®. ArteFill is the first and only non-resorbable aesthetic injectable implant approved by the FDA. The product is indicated for the correction of facial wrinkles known as nasolabial folds, or smile lines. Unlike existing dermal fillers that are completely metabolized by the body, ArteFill represents the first product in a new category of non-resorbable dermal fillers providing a permanent support structure for enduring wrinkle correction. Artes Medical intends to begin marketing and selling ArteFill to dermatologists, plastic surgeons and cosmetic surgeons in the U.S. through the Company’s direct sales force. [more]

Comparative Clinical Trial Results Announced for the Treatment of Nasolabial Folds at the 2006 American Society of Dermatologic Surgery (ASDS) Annual Meeting

BRIDGEWATER, NJ, [October 30, 2006] – Dermik Laboratories, the dermatology business of sanofi-aventis U.S. LLC, announced today that results from a pivotal trial show that Sculptra®(injectable poly-L-lactic acid) demonstrated significantly greater improvement and longer-lasting effects compared to CosmoPlastTM CosmoPlast is a trademark of INAMED Corporation. Collagen Implant, human-based collagen, in the treatment of nasolabial fold wrinkles. Sculptra belongs to a unique class of injectables that work to stimulate a progressive increase in dermal thickness. Sculptra is currently under investigation for the treatment of nasolabial fold wrinkles.These data were presented at the 2006 American Society of Dermatologic Surgery (ASDS) Annual Meeting in Palm Springs, CA. [more]